Expert Insights On Decentralized Trials

  1. Decentralized Clinical Trials: Does Your Strategy Include These Facets? 9/30/2021

    Decentralized clinical trials have increased in response to the COVID-19 pandemic, yet this may be due to a convergence of two factors already in play: our reliance on the use of digital health technologies and a move by the FDA and industry toward patient-focused, real-world clinical trials that leverage the technological advances already available.

  2. 3 Steps To Getting Your First Decentralized Trial Greenlit & Executed 8/17/2021

    Decentralized trials are complex, yes, but they are just a different kind of complex. Halloran Consulting unpacks the top three strategies to consider before you begin your decentralized trial design and champion your vision to executives.

  3. 4 Imperatives For Updating Our Clinical Quality Systems Approach For 2022 Pharma 7/29/2021

    The clinical quality management systems approach developed 20 years ago is not sustainable in the today’s industry because we've seen dramatic industry changes in outsourcing, remote monitoring, the use of electronic systems in clinical research, and more. But how do we update our approach for 2022 pharma? This article examines 4 imperatives, including how to accomplish them.

  4. 3 Easy Ways To Implement Tech & Modernize Your Clinical Trial 6/24/2021

    The life sciences industry’s digital transformation has provided the tools to overcome many of the industry’s problems and has unlocked new avenues for the role of tech in clinical trials. Going forward, clinical execs can use tech in a multitude of ways to power clinical trials.

  5. Decentralized Trials: Trends & Technology Propelling Home Healthcare Services 6/15/2021

    Moving some trial site activities into patients’ homes has been shown to increase recruitment by 60% or more, and it typically maintains patient retention at over 90%. This article delves into research regarding trends and technology enabling decentralized trials.

  6. Incorporating The Voices Of Parents And Children In Pediatric Clinical Trials 3/9/2021

    Pediatric trials are far more complex than simply evaluating a therapy in the context of a child’s disease or illness. They are a family affair that must accommodate the diverse needs of parents and other family members caring for those children. This article discusses recent survey findings from the Center for Information and Study on Clinical Research Participation.

  7. Best Practices For Implementing Decentralized Clinical Trials 1/12/2021

    While the experience design related to the patient is paramount to the adoption of decentralized clinical trial technology, the interrelated experience and incentives for all stakeholders must be fully aligned to realize the full benefits of these platforms.

  8. ICH E6(R3) – Opportunities For Collaborative Alignment Between Stakeholders On eSource & RWE Priorities 12/8/2020

    During the 2020 Avoca Quality and Innovation Summit, an interactive brainstorming system was used during a workshop on ICH E6(R3) to gather industry executives’ insights about guidance that would more rapidly and effectively enable quality adoption of innovative trial designs and technology

  9. 3 Steps To Get A Virtual Clinical Trial Up And Running 10/20/2020

    Despite the existence of innovative technologies, they are only one piece of a complicated puzzle needed to successfully implement virtual clinical trial models. It’s critical that sponsors also consider these three key steps for achieving sustainable change in the bold, patient-centric move to virtual clinical trials.

  10. Capacity & Competency Of The Clinical Research Workforce — Today & Tomorrow 9/29/2020

    It’s not simply an issue of supply and demand. It’s closer to life and death. Put bluntly, we may not be able to keep up with future clinical trial demand because our workforce isn’t growing fast enough. In fact, by some metrics, we’re already falling behind.